ID PADI1_MOUSE Reviewed; 662 AA. AC Q9Z185; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1999, sequence version 1. DT 24-JAN-2024, entry version 158. DE RecName: Full=Protein-arginine deiminase type-1; DE EC=3.5.3.15 {ECO:0000250|UniProtKB:Q9ULC6}; DE AltName: Full=Peptidylarginine deiminase I; DE AltName: Full=Protein-arginine deiminase type I; GN Name=Padi1; Synonyms=Pad1, Pdi1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Epidermis, and Uterus; RX PubMed=10092850; DOI=10.1046/j.1432-1327.1999.00083.x; RA Rusd A.A., Ikejiri Y., Ono H., Yonekawa T., Shiraiwa M., Kawada A., RA Takahara H.; RT "Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, RT type III and type IV, and the expression pattern of type I in mouse."; RL Eur. J. Biochem. 259:660-669(1999). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=129/SvJ; RX PubMed=15087120; DOI=10.1016/j.gene.2003.12.038; RA Chavanas S., Mechin M.-C., Takahara H., Kawada A., Nachat R., Serre G., RA Simon M.; RT "Comparative analysis of the mouse and human peptidylarginine deiminase RT gene clusters reveals highly conserved non-coding segments and a new human RT gene, PADI6."; RL Gene 330:19-27(2004). RN [3] RP CHARACTERIZATION, AND TISSUE SPECIFICITY. RX PubMed=1778991; DOI=10.1093/oxfordjournals.jbchem.a123636; RA Terakawa H., Takahara H., Sugawara K.; RT "Three types of mouse peptidylarginine deiminase: characterization and RT tissue distribution."; RL J. Biochem. 110:661-666(1991). CC -!- FUNCTION: Catalyzes the deimination of arginine residues of proteins. CC {ECO:0000250|UniProtKB:Q9ULC6}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-arginyl-[protein] = L-citrullyl-[protein] + NH4(+); CC Xref=Rhea:RHEA:18089, Rhea:RHEA-COMP:10532, Rhea:RHEA-COMP:10588, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:28938, ChEBI:CHEBI:29965, CC ChEBI:CHEBI:83397; EC=3.5.3.15; CC Evidence={ECO:0000250|UniProtKB:Q9ULC6}; CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; CC -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q9ULC6}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9ULC6}. CC -!- TISSUE SPECIFICITY: Expressed only in the epidermis and uterus. CC {ECO:0000269|PubMed:1778991}. CC -!- DEVELOPMENTAL STAGE: Expressed during the estrus cycle. Expression is CC maximum at proestrus and moderate at estrus. Not expressed in diestrus CC and metaestrus phases. CC -!- INDUCTION: By estrogen. CC -!- SIMILARITY: Belongs to the protein arginine deiminase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB013848; BAA34181.1; -; mRNA. DR EMBL; AB121692; BAD16625.1; -; Genomic_DNA. DR CCDS; CCDS18856.1; -. DR PIR; PH0203; PH0203. DR RefSeq; NP_035189.1; NM_011059.2. DR AlphaFoldDB; Q9Z185; -. DR SMR; Q9Z185; -. DR STRING; 10090.ENSMUSP00000026378; -. DR PhosphoSitePlus; Q9Z185; -. DR MaxQB; Q9Z185; -. DR PaxDb; 10090-ENSMUSP00000026378; -. DR ProteomicsDB; 294101; -. DR Antibodypedia; 14640; 104 antibodies from 16 providers. DR DNASU; 18599; -. DR Ensembl; ENSMUST00000026378.4; ENSMUSP00000026378.4; ENSMUSG00000025329.4. DR GeneID; 18599; -. DR KEGG; mmu:18599; -. DR UCSC; uc008vnh.1; mouse. DR AGR; MGI:1338893; -. DR CTD; 29943; -. DR MGI; MGI:1338893; Padi1. DR VEuPathDB; HostDB:ENSMUSG00000025329; -. DR eggNOG; ENOG502QVJA; Eukaryota. DR GeneTree; ENSGT00940000153217; -. DR HOGENOM; CLU_021911_0_0_1; -. DR InParanoid; Q9Z185; -. DR OMA; VEVFMVY; -. DR OrthoDB; 3956477at2759; -. DR PhylomeDB; Q9Z185; -. DR TreeFam; TF331952; -. DR Reactome; R-MMU-3247509; Chromatin modifying enzymes. DR BioGRID-ORCS; 18599; 4 hits in 80 CRISPR screens. DR PRO; PR:Q9Z185; -. DR Proteomes; UP000000589; Chromosome 4. DR RNAct; Q9Z185; Protein. DR Bgee; ENSMUSG00000025329; Expressed in uterine cervix and 34 other cell types or tissues. DR ExpressionAtlas; Q9Z185; baseline and differential. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0005829; C:cytosol; ISO:MGI. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB. DR GO; GO:0004668; F:protein-arginine deiminase activity; ISS:UniProtKB. DR Gene3D; 2.60.40.1700; Protein-arginine deiminase, central domain; 1. DR Gene3D; 2.60.40.1860; Protein-arginine deiminase, N-terminal domain; 1. DR InterPro; IPR008972; Cupredoxin. DR InterPro; IPR004303; PAD. DR InterPro; IPR013530; PAD_C. DR InterPro; IPR036556; PAD_central_sf. DR InterPro; IPR013732; PAD_N. DR InterPro; IPR038685; PAD_N_sf. DR InterPro; IPR013733; Prot_Arg_deaminase_cen_dom. DR PANTHER; PTHR10837; PEPTIDYLARGININE DEIMINASE; 1. DR PANTHER; PTHR10837:SF11; PROTEIN-ARGININE DEIMINASE TYPE-1; 1. DR Pfam; PF03068; PAD; 1. DR Pfam; PF08527; PAD_M; 1. DR Pfam; PF08526; PAD_N; 1. DR PIRSF; PIRSF001247; Protein-arginine_deiminase; 1. DR SUPFAM; SSF49503; Cupredoxins; 1. DR SUPFAM; SSF55909; Pentein; 1. DR SUPFAM; SSF110083; Peptidylarginine deiminase Pad4, middle domain; 1. DR Genevisible; Q9Z185; MM. PE 1: Evidence at protein level; KW Calcium; Cytoplasm; Hydrolase; Metal-binding; Reference proteome. FT CHAIN 1..662 FT /note="Protein-arginine deiminase type-1" FT /id="PRO_0000220024" FT ACT_SITE 644 FT /note="Nucleophile" FT /evidence="ECO:0000250|UniProtKB:Q9Y2J8" FT BINDING 153 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 155 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 155 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 157 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 157 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 164 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 175 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 178 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 178 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 350 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 352 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 363 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 370 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 371 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 374 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 408 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" FT BINDING 411 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000250|UniProtKB:Q9ULC6" SQ SEQUENCE 662 AA; 73824 MW; F9A6C7DFF1031D8A CRC64; MASPRAVQLS LRKPTHAVCV VGVETLVNVY SDVPKGAKTF GVSGSSEVKI YMVYDPSRVA EPAGWAHWPL DANVDVVVVA DTVSKDLYDF KVKVSYFESQ EAAALAHSVL YLTAVDVSLD VDTGRTGKVK KGSGDKKTWR WGPGGSGAIL LVNCDRDIHG SREDLHANHL KSLEDLQDMS PMVLSCGGPD ELFESHKLVL KASLSDSRRL KVFCARGGTS LSNYKQVLGP RHSSYEVERH SGERAIQFYV EGLAFPDASF SGLLSLSVSL VDTRPLSEVS VFTDSVTFRV APWIMTPNTQ PPLELYVCSV TDIHGRNDKF LEDMSHLATK ANCKLVVCPR AENRNDRWIQ DELEFGYIDA PHKSFPVVFD SPRNRGLRDF ALKRILGPDF GYVTREIEFA GASGLDSFGN LDVSPPVRVG NTDYPLGRIL IGGSFPKPSG RRMARVVRDF LQAQQVQSPV ELYSDWLSVG HVDEFLSFVP TSDQKGFRLL LASPSACLQL FQEKKEEGYG EAEQFDGLKH KAKRSINDIL ADKHLRRDSA HVQKCIDWNR EVLKRELGLS ESDIVDIPQL FFLKGAYAEA FFPDMVNMVV LGKYLGIPKP FGPLINGRCC LEEKVRSLLE PLGLRCVFID DFLFYHQLLG EIHCGTNVRR KPFTFKWWNS VP //